Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 8 papers. Top paper: “The SGLT2 inhibitor Empagliflozin attenuates interleukin-17A-induced human aortic smooth muscle cell proliferation and migration by targeting TRAF3IP2/ROS/NLRP3/Caspase-1-dependent IL-1β and IL-18 secretion”.
Yusuke Higashi, Tadashi Yoshida, Srinivas Mummidi, Annayya R. Aroor, Jacob J. Russell +4 more
Laurel A. Grisanti, Scott M. Brown, Chastidy A. Bailey, Shawn B. Bender, Bysani Chandrasekar +1 more
Srinivas Mummidi, Sharlene M. Day, Sergiy Sukhanov, Shawn B. Bender, Bysani Chandrasekar +1 more
Adam G. Goodwill, Hana E. Baker, Gregory M. Dick, Cooper M. Warne, Selina M. Tucker +8 more
Chastidy A. Bailey, Scott M. Brown, Vincent G. DeMarco, Srinivas Mummidi, Shawn B. Bender +2 more
Adam G. Goodwill, Hana E. Baker, Gregory M. Dick, Cooper M. Warne, Chastidy A. Bailey +6 more
Ian C. Hsu, Alex Meuth, Scott M. Brown, Chastidy A. Bailey, Christian G. Aragonez +11 more
Tadashi Yoshida, Lixin Ma, Li E. Lee, Daniel J. Davis, Laurel A. Grisanti +5 more